Phase 2 Study of Cabozantinib (XL184) in a Cohort of Patients With Castration-Resistant Prostate Cancer (CRPC) and Measurable Soft Tissue DiseaseDavid C Smith,Matthew R Smith,Eric J Small,Christopher J Sweeney,Razelle Kurzrock,Michael S Gordon,Nicholas J Vogelzang,Christian Scheffold,Marcus D Ballinger,Maha Hussainmag(2011)引用 25|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要